D
NeuroPace, Inc. NPCE
$16.36 -$0.14-0.85% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

09/30/2025 06/30/2025 03/31/2025 12/31/2024 09/30/2024
Net Income 14.61% 13.23% 21.27% 17.64% 25.89%
Total Depreciation and Amortization 8.69% 9.98% 10.72% 10.22% -11.34%
Total Amortization of Deferred Charges -12.55% -29.08% -33.00% -19.43% -6.59%
Total Other Non-Cash Items -2.58% -7.01% -10.80% -8.69% -7.05%
Change in Net Operating Assets -114.24% -80.58% -382.07% -119.52% -37.62%
Cash from Operations 1.12% 5.75% -2.12% 8.89% 31.86%
Capital Expenditure 8.36% -65.38% -64.83% -76.88% -23.05%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -81.48% -74.07% -56.13% -59.91% -62.37%
Cash from Investing -83.56% -76.26% -57.27% -60.94% -63.10%
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock 466.92% 669.40% 700.86% -40.08% 2,620.56%
Repurchase of Common Stock -5,970.46% -6,218.79% -6,462.47% -240.15% -265.49%
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- 60.09%
Cash from Financing 69.44% 161.70% 200.01% -46.76% 5,296.89%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -8.26% 100.70% 123.34% -140.41% 41.50%